Senior insider sale
ARROWHEAD PHARMACEUTICALS, INC. — senior position signals high conviction
$566.0K
8.37K shares
What this filing means
WADDILL WILLIAM D. plans to sell 8.37K shares of ARROWHEAD PHARMACEUTICALS, INC. valued at approximately $566.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/19/2025ACC: 0001628280-25-058254
Director
Since Jan 2019
8.37K
Shares to sell
$566.0K
Approx. market value
16.73K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Compensation
Compensation
12/18/2024
16.73KTotal acquired16.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/18/2024 | Compensation Compensation | 16.73K | — |
| Total | 16.73K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
8.37K
Market value
$566.0K
12/19/2025
Total
Units
8.37K
Value
$566.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/19/2025 | 8.37K | $566.0K | NASDAQ | Planned |
| Total | 8.37K | $566.0K | ||